Variability over Time of Haemostatic and Other Cardiovascular Risk Factors in Patients Suffering from Angina Pectoris

Summary

The variability of haemostatic factor measurements in patients presenting with angina pectoris is investigated. In all, 219 middle aged patients (almost all men) provided repeat measurements 2.5 years apart on a battery of haemostatic and haematological tests and other cardiovascular risk factors. Correlations between repeat measurements were lower than might be expected in a healthy population, reflecting a relatively large degree of variability within individuals over time. The highest correlations observed for haemostatic factors were for von Willebrand factor related antigen (r = 0.48) and fibrinogen (r = 0.45). The correlations were generally lower amongst patients who had undergone coronary surgery or angioplasty between the two measurements. We conclude that the underlying relationship of fibrinogen to coronary risk must be much greater than is generally appreciated, since even single measurements are found to be important predictors of risk, despite only moderate stability over time. The very low correlations for β-thromboglobulin (r = 0.10) and platelet factor 4 (r = 0.03) which were observed in this study casts doubt on their potential usefulness as predictors of long-term cardiovascular risk.

• References

• 1 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537
• 2 Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505
• 3 Stone MC, Thorp JM. Plasma fibrinogen – a major coronary risk factor. J R Coll Gen Pract 1985; 35: 565-569
• 4 Kannel WB, Wolf PA, Castelli WP, D’Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. J Am Med Assoc 1987; 258: 1183-1186
• 5 Yarnell JWG, Baker IA, Sweetman PM, Bainton D, O’Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity and white blood cell count are major risk factors for ischaemic heart disease. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation 1991; 83: 836-844
• 6 Cooper J, Douglas AS. Fibrinogen level as a predictor of mortality in survivors of myocardial infarction. Fibrinolysis 1991; 5: 105-108
• 7 Thompson SG, van de LooJ, Haverkate F. Principal results of the ECAT Angina Pectoris Study. Thromb Haemostas 1991; 65: 816 (abstr).
• 8 Thompson SG, Martin JC, Meade TW. Sources of variability in coagulation factor assays. Thromb Haemostas 1987; 58: 1073-1077
• 9 ECAT Angina Pectoris Study Group. ECAT angina pectors study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 1993; 14: 8-17
• 10 European Concerted Action on Thrombosis and Disabilities (ECAT). ECAT Assay Procedures: A Manual of Laboratory Techniques. Jespersen J, Bertina RM, Haverkate F. (eds). Dordrecht: Kluwer; 1992
• 11 European Concerted Action on Thrombosis and Disabilities (ECAT). The impact of sequential quality assessment exercises on laboratory performance: the multicentre ECAT angina pectoris study. Thromb Haemostas 1991; 65: 149-152
• 12 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246
• 13 Thompson SG. A method of analysis of laboratory data in an epidemiological study where time trends are present. Stat Med 1983; 2: 147-153
• 14 Meade TW, Miller GJ, Rosenberg RD. Characteristics associated with the risk of arterial thrombosis and the prethrombotic state. In: Thrombosis in Cardiovascular Disorders. Fuster V, Verstraete M. (eds). Philadelphia: Saunders; 1992. pp 79-97
• 15 Rosner B, Willett WC, Spiegelman D. Correction of logistic regression relative’ risk estimates and confidence intervals for systematic within-person measurement error. Stat Med 1989; 8: 1051-1069
• 16 Thompson SG, Pocock SJ. The variability of serum cholesterol measurements: implications for screening and monitoring. J Clin Epidemiol 1990; 43: 783-789
• 17 Armitage P, Fox W, Rose GA, Tinker CM. The variability of measurements of casual blood pressure II. Survey experience. Clin Sci 1966; 30: 337-344
• 18 Hölzel WGE. Intra-individual variation of some analytes in serum of patients with insulin-dependent diabetes mellitus. Clin Chem 1987; 33: 57-61
• 19 Stout RW, Crawford V. Seasonal variations in fibrinogen concentrations among elderly people. Lancet 1991; 338: 9-13
• 20 Folsom AR, Davis CE, Marcucci G, Wu KK. Seasonal fibrinogen fluctuations among elderly people. Lancet 1991; 338: 629